深度学习驱动的宫颈癌VMAT自动计划框架
本研究纳入458例宫颈癌VMAT计划,开发两阶段级联深度学习端到端自动计划框架,将预测剂量经脚本转为Monaco优化目标。自动计划在靶区覆盖不劣于手动计划的同时,膀胱、直肠、小肠和脊髓的DVH指标降低2%–35%(均p<0.05),3%/3 mm gamma通过率98.1%高于手动计划的97.9%。
要点
- 两阶段DL框架可从CT和结构掩膜预测并细化剂量,经脚本转为Monaco目标迭代优化。
- 自动计划靶区覆盖与手动计划相当,膀胱、直肠、小肠、脊髓DVH指标降低2%–35%(均p<0.05)。
- 3%/3 mm gamma通过率自动计划98.1%,高于手动计划97.9%。
核心结论
- 所提出的自动计划框架自动化程度高且具临床适用性,可作为支持放疗工作流的可靠工具。
研究设计与样本
- 共纳入458例宫颈癌VMAT计划,分为训练、验证和测试队列。
- 开发两阶段级联深度学习端到端自动计划框架:第一阶段从CT和结构掩膜预测粗略剂量,第二阶段利用四个束带先验和复合损失细化。
- 将细化预测剂量的DVH终点经脚本模块转换为Monaco目标进行迭代优化。
- 采用Dose、DVH和snDVH评分、消融实验及与手动计划的质量、临床评估和可交付性比较进行评价。
主要发现
- 所提DL方法表现最佳,Dose评分为2.114 ± 0.218 Gy,DVH评分为1.194 ± 0.295 Gy,snDVH评分为2.027 ± 0.586。
- 与手动计划相比,端到端自动计划在保持靶区覆盖的同时,膀胱、直肠、小肠和脊髓的所有DVH指标降低2%–35%(均p<0.05)。
- 端到端自动计划在3%/3 mm gamma标准下通过率为98.1%,高于手动计划的97.9%。
关键数值与推荐
- Dose评分2.114 ± 0.218 Gy、DVH评分1.194 ± 0.295 Gy、snDVH评分2.027 ± 0.586为所提DL方法在测试中的结果。
- 膀胱、直肠、小肠和脊髓的所有DVH指标较手动计划降低2%–35%,均p<0.05。
- 3%/3 mm gamma通过率:端到端自动计划98.1%,手动计划97.9%。
临床怎么用
- 该框架可基于CT和结构掩膜自动生成宫颈癌VMAT计划,并经脚本转换为Monaco优化目标。
- 自动计划在保持靶区覆盖的同时降低膀胱、直肠、小肠和脊髓DVH指标,gamma通过率不低于手动计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The rapid and efficient generation of high-quality, dose-consistency volumetric modulated arc therapy (VMAT) plans remains challenging in radiotherapy. This study proposes a deep learning (DL) end-to-end (E2E) auto-planning framework and validate its practicality and feasibility for clinical implementation. MATERIALS AND METHODS: A total of 458 cervical cancer VMAT plans were enrolled and split into training, validation, and test cohorts. An E2E auto-planning framework with a two-stage cascaded DL network was developed: Stage 1 predicted coarse dose from CT and structure masks, and Stage 2 refined it using four beam-band priors and a composite loss. Dose-volume histogram (DVH) endpoints from refined predicted dose were converted into Monaco objectives via a scripting module for iterative optimization. Performance was evaluated with Dose, DVH, and snDVH scores, ablations, and comparisons with manual plans in terms of quality, clinical evaluation and deliverability. RESULTS: The proposed DL method achieved the best performance, with Dose score, DVH score and snDVH score of 2.114 ± 0.218 Gy, 1.194 ± 0.295 Gy and 2.027 ± 0.586, respectively. Compared with manual plans, E2E auto-plans preserved target volume coverage while reducing all DVH metrics for bladder, rectum, small intestine, and spinal cord by 2% - 35% (all p < 0.05). The gamma passing rate of E2E auto-plans was higher than manual plans in the 3%/3 mm gamma criterion (98.1% vs. 97.9%). CONCLUSION: The proposed auto-planning framework demonstrated a high level of automation and clinical applicability, offering a reliable and promising tool to support radiotherapy workflows. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Ning B, Liang X, Cui Z, et al. A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy. Radiat Oncol. 2026. PMID: 41981451. doi:10.1186/s13014-026-02842-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。